From left to right: Tom Britton (Co-founder and CTO) and Goncalo de Vasconcelos (Co-founder and CEO)
Oval, a cutting-edge medical technology company, designing and producing auto-injectors to enhance medical safety and address trypanophobia (fear of needles), has been acquired by US-based healthcare contract manufacturer SMC Ltd. Oval Medical raised £1,118,647 in August 2014 via the SyndicateRoom platform, with 40 SyndicateRoom investors contributing to this total. SMC Ltd. is acquiring Oval to build on its existing business in the drug delivery device market, paving the way to grow and to develop further Oval’s core auto-injector technology.
‘This is an incredibly proud moment for SyndicateRoom and fantastic news for the investors who chose to buy into Oval two years ago when it raised through the platform,’ said Gonçalo de Vasconcelos, CEO, SyndicateRoom. ‘It also proves the value of our unique investor-led model. All SyndicateRoom investors had access to the same class of share and the same price per share as the lead investors and both are enjoying the rewards of this acquisition fairly.’
This comes after an impressive list of accolades for SyndicateRoom. At the end of November, the company picked up two awards at the second annual Growth Investor Awards, organised by Intelligent Partnership. It was named Best Investment Platform for the second year running and also Industry Game-Changer. Judges were impressed by ”their democratic philosophy and innovations such as their EIS fund, tie up with the London Stock Exchange to give retail investors access to IPOs and their referral arrangement with Ratesetter.”
And the awards have just kept coming. At the end of November Gonçalo de Vasconcelos was shortlisted for the Entrepreneur of the Year award at the 18th annual Amazon Growing Business Award. Created by Real Business, sponsored by Amazon and supported by the CBI, The Amazon Growing Business Awards recognise SME and entrepreneurial success.
The company has also launched new products to enable investors to better access sophisticated investment opportunities this year. The WatchList is one such product, which offers valuable support and opportunity to private investors interested in investing in smaller AIM-quoted companies.online